Skip to main content

Table 3 Frequencies of variants among patients with any variant identified by the panela

From: The Latin American experience with a next generation sequencing genetic panel for recessive limb-girdle muscular weakness and Pompe disease

Gene

Variant Frequency, n (%)

Disease

Molecular Diagnosis Frequency, n (%)

(N = 335)

DYSF

468 (39.89)

LGMD R2

127 (37.91)

CAPN3

247 (21.05)

LGMD R1

90 (26.87)

ANO5

101 (8.61)

LGMD R12

20 (5.97)

GAA

94 (8.01)

Pompe disease

9 (2.69)

SGCA

90 (7.68)

LGMD R3

33 (9.85)

FKRP

62 (5.29)

LGMD R9

18 (5.37)

TCAP

42 (3.58)

LGMD R7

15 (4.48)

SGCB

32 (2.73)

LGMD R4

10 (2.99)

SGCG

24 (2.05)

LGMD R5

9 (2.69)

SGCD

13 (1.12)

LGMD R6

4 (1.19)

  1. a Includes pathogenic variants and variants of uncertain significance (VUS)